Nippon Insure Co., Ltd.
Nippon Insure guarantees rent payments as more Japanese landlords stop accepting personal guarantors, with an aging population adding demand. Cash accumulates in a business earning 32% ROCE, making its 10% dividend payout and policy for cash use central to valuation.
Company
Nippon Insure Co., Ltd.
ニッポンインシュア株式会社
A rent guarantee company collecting initial, renewal and monthly fees. Guarantees account for 94% of revenue.
- Last Close
- ¥2,418
- May 18, 2026 · −31% from Aug-25 peak · +257% off Aug-24 trough
- Market Cap / enterprise value (EV)
- ¥6.94bn / ¥4.67bn EV
- net cash ¥2.27bn (33% of cap) · capital return at ~10% payout
- EV / OP · forward
- 5.3x
- trailing 6.2x · vs Aug-25 peak ~8.8x fwd · strict pass (≤12x)
- ROCE · trailing
- 32%
- FY09/23 27% → FY09/24 26% → FY09/25 32% · re-accelerating
- OP Margin · group
- 28% · seg-wtd
- reported 20.3% · 8.2pp corporate-overhead bridge · 1H FY09/26 actual 28.6%
- Shares & Float
- 2.87M sh · ~60% float
- founder bloc ~30% · Toyoshima RE 9.9% (filing basis) · avg daily turnover ~¥49M (60-day)
What moved the share price over the past two years?
stock price has approximately quadrupled from ¥897 in May 2024 to ¥3,485 in August 2025. In addition to the initial guarantee fee, renewal guarantee fees and monthly guarantee fees will accumulate from existing contracts, and it is assumed that profits will increase more than sales growth. Since then, it has lost about a third of its gains. The turning point was the FY9/25 full-year financial results and FY9/26 company plan announced in November 2025. Operating profit in FY9/25 increased by +81.5%, but the next year's plan was only +16.4%.
01 · The rally Nippon Insure is a Standard Market rent guarantee company, with guarantees accounting for about 94% of FY9/25 sales; listed peers include Casa (7196) and Zenhoren (5845). It guarantees rent for tenants unable or unwilling to provide a guarantor. Property managers submit applications through Cloud Insure, with underwriting using arrears data accumulated since October 2008 and JICC/LICC membership data. After paying landlords in arrears cases, it collects through an internal call center and seven regional locations. H1 FY9/26 collection was 99.1% and the incidence of recourse receivables 6.2%. Initial, renewal and monthly guarantee fees form three revenue streams; accumulated contracts build recurring renewal and monthly income. The shares reached a post-IPO low of ¥678 on August 5, 2024, traded around ¥800–900, then broke out after November 14 FY9/24 results showing sales up 12% and OP up 43%. They rose to ¥1,743 in spring 2025 and ¥3,485 on August 18, up 414% from the low. FY9/25 sales grew 16.0% to ¥3,737M and OP 81.5% to ¥759M as recurring fees lifted margins faster than SG&A. ROCE on average invested capital rose from 25.6% to 32.3%. About 8.8x next-twelve-month EV/EBIT at the high assumed this profit level would become the new steady state.
02 · The reversal The reversal began on November 14, 2025. FY9/25 OP was ¥759M (+81.5%), with a 20.3% consolidated margin and about 28% on a segment-weighted basis. FY9/26 guidance was ¥4,233M sales (+13.3%) and ¥883M OP (+16.4%). Slower OP growth made August’s valuation harder to justify. FY9/25’s recurring renewal and monthly fees had changed an earnings model centered on initial fees, but that step-up does not repeat at the same rate annually. FY9/26 also included estimated annual amortization of ¥40–60M for the ¥306M Cloud Insure upgrade through November 2027, and staffing investment in cities including Nagoya. H1 initial guarantee contracts fell 1.4% to 15,145; new inflows are needed to replenish recurring fees. The shares fell toward ¥2,200–2,400 around December’s AGM and temporarily stabilized there as investors priced in more normal profit growth against higher costs.
03 · Current position H1 FY9/26 results were released on May 14, 2026. Sales were ¥2,064M (+15.6%), OP ¥590M (+52.5%) and net profit ¥417M (+53.3%). The 28.6% OP margin was 7.7ppt above full-year guidance of 20.9%. H1 achieved 49% of the full-year sales plan and 67% of the OP plan. Incremental OP margin (change in OP divided by change in sales) was 0.73, slightly above 0.66 between FY9/24 and FY9/25. Credit quality also improved: the incidence of recourse receivables fell from 6.4% to 6.2%, and the collection rate rose from 98.8% to 99.1%. The company may be selecting contracts for profitability and collectability rather than pursuing volume indiscriminately. The equity ratio reached 51.4%, cash and deposits ¥2,760M and net cash ¥2,265M, or 33% of its ¥6,939M market capitalization. The FY9/26 dividend is planned to rise from ¥19 to ¥22, but the payout remains about 10%. No buyback has been authorized and management has made no comment about revising the dividend policy. Over the next four quarters, watch whether H1’s high incremental margin continues in H2, whether initial guarantee contracts recover through the Nagoya branch and new business partners, and whether November’s FY9/26 results bring a stronger capital policy from a business earning 32% ROCE with ¥2.26bn in net cash.
Three issues the market is looking at
Based on's most recent quarterly financial results and the Q&A at the IR briefing, there are three points at issue. Will the high profit growth continue, will the slowdown in new contracts affect future renewal fees, and will shareholder returns be expanded?
Three points to note that affect capital efficiency
List three evaluation materials related todisclosure and capital policy. In either case, the evaluation can be changed to without waiting for profits to increase further.
3 scenarios
Three scenarios for the next four quarters show possible valuations under different combinations of disclosure, results and capital policy. They are analytical reference points, not predictions.
- H2 FY9/26 operating profit margin20%For the full year, sales came in at around 20.9% of the company's plan.
- The number of first-time guarantee contracts in FY9/26 was higher than that in FY9/25.33,749 itemsThis is the second consecutive year of sluggish growth.
- As of FY9/26, we maintained the dividend payout ratio target of 10%, and there was no resolution to acquire treasury stock, resulting in net cash¥3bnexceed.
- Neither the breakdown of related party transactions nor the breakdown of the number of initial guarantee contracts each quarter is disclosed.
- The rate of claims owed has worsened to over 6.5%, and the stock of renewal guarantee fees has been affected by the deterioration in credit.
is equivalent to ~4.4~5.3 times in FY26 next 12 months EV/EBIT. This is clearly lower than the 7 to 10 times expected in the private market for similar domestic credit businesses, and will only occur if the market continues to place a strong undervaluation on the sustainability of renewal guarantee fees.
- Q3 Operating profit margin in FY9/26 (August 2026)≥25%・Sales growth rate ≥14%, FY26 full year operating profit≥¥950M(+8% compared to company plan).
- The number of first-time guarantee contracts in FY9/26 remained flat to slightly increased compared to FY9/25 (contributing to the launch of the Nagoya branch and new business partners).
- Announced either raising the dividend payout ratio target or acquiring treasury stock for the first time in FY9/26 financial results.
- A more detailed breakdown of related party transactions will be disclosed in the FY9/26 securities report.
- Q3 Operating profit margin in FY9/26≥27%・Sales growth rate ≥15%, FY26 full year operating profit≥¥1,050M(+19% compared to company plan) and announced an upward revision.
- The number of initial guarantee contracts is+5% or more compared to the same period last year(The launch of the Nagoya branch and adjacent areas such as nursing care and hospitalization expense guarantees contributed).
- Dividend payout ratio target set in FY9/26 financial results≥25%The total return policy will also be shown.
- In the FY9/26 securities report, we will show the multi-year trends in related party transactions and our policy for reducing dependence.
- The incidence rate of claim claims is≤6.0%further improved and maintained a recovery rate of over 99%.
bullish scenario, exceeds the August 2025 high of ¥3,485, and is at a level that takes into account a revaluation of ~9-10x in EV/EBIT for the next 12 months. Exceeding this would require a multi-year view in which adjacent areas such as nursing care and hospitalization expense guarantees become a secondary source of growth, which is outside of this four-quarter scenario.
This material is not investment advice.
Conflict of Interest Disclosure. JII, its officers and affiliates do not own or buy or sell securities of companies featured in JII's research reports. If JII receives paid work from a target company, this fact will be disclosed in the relevant report. The information published by JII is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell specific securities.
Japan Investor Interface Co., Ltd. (“JII”) is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator under Japan’s Financial Instruments and Exchange Act and does not hold an Investment Advisory and Agency Business registration. JII does not provide investment advice or solicit the purchase, sale or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
This publication is an analytical article for educational and research purposes. It does not constitute Investment Advisory and Agency Business under Japan’s Financial Instruments and Exchange Act and does not solicit or recommend transactions in any security. Japan Investor Interface Co., Ltd. (“JII”) accepts no responsibility for investment decisions based on this publication. Make investment decisions on your own responsibility and independent research.